Skip to content
Home » Second European Parliament Roundtable Addresses Urgent Needs in Lung Cancer Care

Second European Parliament Roundtable Addresses Urgent Needs in Lung Cancer Care

    Brussels, 9 April 2024 – Together with stakeholders from the Swedish Institute of Health Economics, the European Lung Cancer Association, and MSD, CPE co-organised a crucial roundtable discussion titled “Fighting Lung Cancer Together as Equals – A Year On”. The event, hosted by MEP Cristian-Silviu Buşoi (EPP), delved into pressing issues surrounding lung cancer management and policy initiatives across Europe.

    In his opening remarks, MEP Buşoi  highlighted the staggering impact of lung cancer in Europe. Despite the ongoing efforts, challenges persist due to varying access to diagnosis and treatment among member states, necessitating greater EU-level attention.

    Domenico Fiorenza, Policy Officer from DG SANTE, provided insights into the multidimensional approach of the European Cancer Plan, aimed at addressing inequalities and enhancing cancer care across member states.

    The panel session featured stakeholders from diverse sectors, including Thomas Hofmarcher, Research Director at the Swedish Institute for Health Economics (IHE), who provided background information on the institute’s role in initiating the call to action on lung cancer treatment and discussed their recent report highlighting the lack of reliable data on drug treatment rates in advanced non-small cell lung cancer across European countries.

    Bardh Manxhuka, Research Analyst at the IHE, also stressed the importance of systematic data collection for evidence-based decision-making in healthcare, emphasising its role in measuring and tracking the quality of cancer care.

    Our CEO Antonella Cardone presented CPE’s advocacy efforts in areas such as tobacco control and access to innovative treatments. She also stressed the importance of civil society involvement, particularly in Eastern European countries, and called for continued support from the European Institutions.

    Senior Cancer Control Officer, Roxana Albu from the European Association of Cancer Leagues (ECL), emphasised the ongoing necessity for funding to distribute the European Code Against Cancer nationally. Additionally, she noted challenges in implementing a national lung cancer screening plan due to uncertainties in medical evidence and the need to consider environmental factors beyond smoking.

    Enrique Terol, Health Counsellor at the Permanent Representation of Spain to the EU outlined Spain’s comprehensive tobacco control plan, focusing on prevention and cessation measures. He also discussed ongoing efforts to assess the cost-effectiveness of lung cancer screening, highlighting the importance of a balanced approach to tobacco control.

    Director General at the EFPIA oncology platform, Nathalie Moll, emphasised efforts to measure access inequalities in cancer care and promote innovation. Moll stressed the importance of multi-stakeholder collaboration to address access challenges and ensure innovations reach patients, considering global and political factors.

    EUREGHA’s Director Michele Calabrò, emphasised the importance of organisational innovation and knowledge exchange at the regional and local level.

    Finally,  Dr Jasper Kunow, Managing Director for the Central Eastern European countries, called on the necessity of multi-stakeholder cooperation to address inequities in lung cancer management and called for intensified efforts to reduce the burden of lung cancer.

    The roundtable concluded with a renewed sense of urgency and commitment to address the challenges posed by lung cancer, highlighting the importance of collective action in the fight against this devastating disease.